US Stock MarketDetailed Quotes

ABCL AbCellera Biologics

Watchlist
  • 2.720
  • +0.050+1.87%
Close Nov 21 16:00 ET
  • 2.750
  • +0.030+1.10%
Post 20:01 ET
803.40MMarket Cap-4459P/E (TTM)

AbCellera Biologics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

AbCellera Biologics Q3 2024 Earnings Date

Currency：USDNov 4, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
8.01M
6.51M
-1.51M
Miss Est.
+21.45%
-1.39%
-18.81%
EPS
-0.13
-0.17
-0.04
Miss Est.
-30.03%
-70.00%
-30.87%
Analyst Rating
Strong Buy

Nov 20, 2024

AbCellera Biologics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 11.812M--
--2024/Q4-- / 7.579M--
Nov 4, 20242024/Q36.507M / 8.015M--
Aug 6, 20242024/Q27.323M / 10.015M--
May 7, 20242024/Q19.954M / 11.005M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 11.812M--
--2024/Q4-- / 7.579M--
Nov 4, 20242024/Q36.507M / 8.015M--
Aug 6, 20242024/Q27.323M / 10.015M--
May 7, 20242024/Q19.954M / 11.005M--

Unlock Free Earnings Estimates

AbCellera Biologics Earnings Reports

  • AbCellera Biologics | 10-Q: Q3 2024 Earnings Report

    Nov 5 05:39

  • AbCellera Biologics | 10-Q: Q2 2024 Earnings Report

    Aug 7 04:59

  • AbCellera Biologics | 10-Q: Q1 2024 Earnings Report

    May 8 04:54

  • AbCellera Biologics | 10-K: FY2023 Annual Report

    Feb 21 11:18

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 20, 2024

    Strong Buy

    • Buy

      87.50%

    • Hold

      12.50%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data